Skip to main content

Advertisement

Log in

Maternal arrhythmias during pregnancy

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Introduction.

An increased incidence of maternal cardiac arrhythmias is observed during pregnancy and they can range from clinically irrelevant isolated premature beats to debilitating supraventricular and ventricular tachycardias.

Discussion.

Management of arrhythmias during pregnancy is similar to that in non-pregnant patients. However, the presence of the foetus and the risk of teratogenicity, the haemodynamic changes, the effect of therapy on labour, delivery and lactation must be evaluated. Antiarrhythmic drug selection depends on the specific arrhythmia being treated and the cardiac condition of the mother. Although no drug is completely safe, most are well tolerated and can be given with relatively low risk. Some antiarrhythmic agents, such as propranolol, metoprolol, digoxin and quinidine, have been extensively tested during pregnancy and have proved to be safe; they should therefore, whenever possible, be used as a first-line. For supraventricular tachycardia, intravenous adenosine may be used to terminate the arrhythmia if vagal manoeuvres fail. If possible, drug therapy should be avoided during the first trimester of pregnancy. When drug treatment fails or is not indicated because of the haemodynamic instability of the patient, direct current cardioversion can be used.

Conclusion.

Most patients with arrhythmias during pregnancy can be treated with an excellent result.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. Allen LD, Shita SK, Sharland GK, Maxwell D, Priestley K (1991) Flecainide in the treatment of fetal tachycardias. Br Heart J 65:46–48

    PubMed  Google Scholar 

  2. Allen NM, Page RL (1993) Administration of procainamide during pregnancy. Clin Pharm 12:58–60

    CAS  PubMed  Google Scholar 

  3. Anderson MH (1997) Heart disease in pregnancy. In: Oakley C (ed) Heart disease in pregnancy. BMJ, London, p 248

  4. Barrilon A, Grand A, Gerbaux A (1974) Treatment of the heart during pregnancy. Ann Med Intern (Paris) 125:437–445

    Google Scholar 

  5. Bellet S (1972) Essentials of cardiac arrhythmias: diagnosis and management. In: Pregnancy. Saunders, Philadelphia, p 257

  6. Berlin CM (1981) Pharmacologic considerations of drug use in the lactating mother. Obstet Gynecol 58 [Suppl]:17–23

    Google Scholar 

  7. Bott-Kanner G, Schweitzer A, Reisner SH, Joel-Cohen SJ, Rosenfeld JB (1980) Propranolol and hydralazine in the management of essential hypertension in pregnancy. Br J Obstet Gynaecol 87:110–114

    CAS  PubMed  Google Scholar 

  8. Bourget P, Pons JC, Delouis C, Fermont L, Frydman R (1994) Flecainide distribution, transplacental passage, and accumulation in the amniotic fluid during the third trimester of pregnancy. Ann Pharmacother 28:1031–1042

    CAS  PubMed  Google Scholar 

  9. Braverman AC, Bromley BS, Rutherford JD (1991) New onset ventricular tachycardia during pregnancy. Int J Cardiol 33:409–412

    CAS  PubMed  Google Scholar 

  10. Briggs G, Freeman RK, Yaffe SJ (1994) Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk, 4th edn. Williams and Wilkins, Baltimore

  11. Briggs G, Freeman RK, Yaffe SJ (1998) Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk, 5th edn. Williams and Wilkins, Baltimore

  12. Brodsky M, Doria R, Allen B, Sato D, Thomas G, Sada M (1992) New-onset ventricular tachycardia during pregnancy. Am Heart J 123:933–941

    CAS  PubMed  Google Scholar 

  13. Brown WW, Bell GG, Alper MH (1976) Acidosis, local anesthesia and newborn. Obstet Gynecol 48:23–30

    Google Scholar 

  14. Brunozzi T, Meniconi L, Chiocchi P, Liberati R, Zuanetti G, Latini R (1988) Propafenone in the treatment of chronic ventricular arrhythmias in a pregnant patient [letter]. Br J Clin Pharmacol 26:489–490

    CAS  PubMed  Google Scholar 

  15. Bullock JL, Harris RE, Young T (1975) Treatment of thyrotoxicosis during pregnancy and propranolol. Am J Obstet Gynecol 121:242–245

    CAS  PubMed  Google Scholar 

  16. Burkart TA, Conti JB (1999) Arrhythmias in the pregnant patients: evaluation and management. Acc Curr J Rev 3:41–44

    Article  Google Scholar 

  17. Camm JA, Garratt CJ (1991) Adenosine and supraventricular tachycardia. N Engl J Med 325:1621–1629

    CAS  PubMed  Google Scholar 

  18. Chaffman M, Brogden RN (1985) Diltiazem: a review of its pharmacological properties and therapeutic efficacy. Drugs 29:387¯454

    CAS  PubMed  Google Scholar 

  19. Chao RC, Ho ESC, Hsieh KS (1992) Fetal atrial flutter and fibrillation: prenatal echocardiographic detection and management. Am Heart J 124:1095–1098

    CAS  PubMed  Google Scholar 

  20. Chow T, Galvin J, McGovern B (1998) Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol 82:581–621

    Article  Google Scholar 

  21. Colin A, Lambotte R (1972) Influence tératogène des médicaments administrés à la femme enceinte. Rev Med Liege 27 [Suppl 1]:39–48

    Google Scholar 

  22. Conradsson TB, Werkö L (1974) Management of heart disease in pregnancy. Prog Cardiovasc Dis 16:407–419

    CAS  PubMed  Google Scholar 

  23. Cottrill M, McAllister RG, Gettes L Jr, Noonan JA (1977) Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition. J Pediatr 91:812–814

    CAS  PubMed  Google Scholar 

  24. Cox JL, Gardner MJ (1993) Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis 36:137–178

    CAS  PubMed  Google Scholar 

  25. Dalvi BV, Chaudhuri A, Kulkarni HL, Purushottam KA (1992) Therapeutic guidelines for congenital complete heart block presenting in pregnancy. Obstet Gynecol 79:802–804

    CAS  PubMed  Google Scholar 

  26. Di Marco JP, Sellers TD, Berne RM, West GA, Belardinelli L (1983) Adenosine: electrophysiologic effects and therapeutic use for treating paroxysmal supraventricular tachycardia. Circulation 68:1254–1263

    PubMed  Google Scholar 

  27. Di Marco JP, Miles W, Akhtar M, Milstein S, Sharna AD, Platia E et al (1990) Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Ann Intern Med 113:104–110

    PubMed  Google Scholar 

  28. Doig JC, McComb JM, Reid DS (1992) Incessant atrial tachycardia accelerated by pregnancy. Br Heart J 67:266–268

    CAS  PubMed  Google Scholar 

  29. Eliahou HE, Silverberg DS, Reisin E, Romen I, Mashiach S, Serr DM (1978) Propranolol for the treatment of hypertension in pregnancy. Br J Obstet Gynaecol 85:431–436

    CAS  PubMed  Google Scholar 

  30. Elkayam U (1992) Pregnancy and cardiovascular disease. In: Braunwald E (ed) Heart disease. Saunders, Philadelphia, p 1790

  31. Elkayam U, Goodwin TM (1995) Adenosine therapy for supraventricular tachycardia during pregnancy. Am J Cardiol 75:521–523

    Article  CAS  PubMed  Google Scholar 

  32. Engelhardt W, Grabitz RG, Funk A, von Bernuth G (1993) Intrauterine treatment of fetal supraventricular tachycardia with digoxin and verapamil. Z Geburtshilfe Perinatol 197:99–103

    CAS  PubMed  Google Scholar 

  33. Frishman WH, Chesner M (1988) Beta-adrenergic blockers in pregnancy. Am Heart J 115:147–152

    CAS  PubMed  Google Scholar 

  34. Gladstone R, Hordof A, Gersony WM (1975) Propranolol administration during pregnancy: effects on the fetus. J Pediatr 86:962–964

    CAS  PubMed  Google Scholar 

  35. Goodwin AP, Pearce AJ (1992) The human wedge. A manoeuvre to relieve aortocaval compression during resuscitation in late pregnancy. Anaesthesia 47:433–434

    CAS  PubMed  Google Scholar 

  36. Greenspoon J (1987) Prosthetic valves, arrhythmias and anticoagulation in pregnancy. In: Clark SL (ed) Critical care obstetrics. Oradell, New Jersey, p 114

  37. Hackett LP, Wojnar-Horton RE, Dusci LH, Ilett KF, Roberts MJ (1990) Excretion of sotalol in breast milk [letter]. Br J Clin Pharmacol 29:277–278

    CAS  PubMed  Google Scholar 

  38. Hagley MT, Cole PL (1994) Adenosine use in pregnancy women with supraventricular tachycardia. Ann Pharmacother 28:1241–1242

    CAS  PubMed  Google Scholar 

  39. Haissaguerre M, Jais P, Shah DC (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666

    CAS  PubMed  Google Scholar 

  40. Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. Litteton, Massachusetts

  41. Hill LM, Malkasian GD (1979) The use of quinidine sulfate throughout pregnancy. Obstet Gynecol 54:366–368

    CAS  PubMed  Google Scholar 

  42. Jaqueti J, Martinez-Hernandez D, Hernandez-Garcia R, Navarro-Gallar F (1990) Adenosine deaminase in pregnant serum. Clin Chem 36:2144

    CAS  PubMed  Google Scholar 

  43. Kerr MG, Scott DB, Samuel E (1964) Studies of the inferior vena cava in late pregnancy. BMJ 1:523–533

    Google Scholar 

  44. Kofinas AD, Simon NV, Sagel H, Lyttle E, Smith N, King K (1991) Treatment of fetal supraventricular tachycardia with flecainide acetate after dogixin failure. Am J Obstet Gynecol 165:630–631

    CAS  PubMed  Google Scholar 

  45. Langer A, Hung CT, McAnulty JA, Harrigan JT, Washigton E (1974) Adrenergic blockade: a new approach to hyperthyroidism in pregnancy. Obstet Gynecol 44:181–186

    CAS  PubMed  Google Scholar 

  46. Lee RV, Rodgers BD, White LM, Harvey RC (1986) Cardiopulmonary resuscitation of pregnant women. Am J Med 81:311–318

    CAS  PubMed  Google Scholar 

  47. Lee W, Cotton D (1989) Peripartum cardiomyopathy: current concepts and clinical managements. Clin Obstet Gynecol 32:54–67

    CAS  PubMed  Google Scholar 

  48. Lees KR, Rubin PC (1987) Treatment of cardiovascular diseases. BMJ 294:358–360

    CAS  PubMed  Google Scholar 

  49. Leffler S, Johnson DR (1992) Adenosine use in pregnancy: lack of effect on fetal heart rate. Am J Emerg Med 10:548–549

    CAS  PubMed  Google Scholar 

  50. Lehmann MH, Hardy MS, Archibald D, Quart B, MacNeil DJ (1996) Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation 94:2534–2541

    Google Scholar 

  51. Leonard RF, Braun TE, Levy AM (1978) Initiation of uterine contractions by disopyramide during pregnancy. N Engl J Med 299:84–85

    CAS  PubMed  Google Scholar 

  52. Lieberman BA, Stirrat GM, Cohen SL, Beard RW, Pinker GD, Belsey E (1978) The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension. Br J Obstet Gynaecol 85:678–683

    CAS  PubMed  Google Scholar 

  53. Liston WA, Adjepon-Yamoah KK, Scott DB (1973) Foetal and maternal lidocaine levels after paracervical block. Br J Anaesth 45:750–754

    CAS  PubMed  Google Scholar 

  54. Mason BA, Ricci-Goodmann J, Koos BJ (1992) Adenosine in the treatment of maternal paroxysmal supraventricular tachycardia. Obstet Gynecol 80:478–480

    CAS  PubMed  Google Scholar 

  55. Mauer A, Devaux L, Lakey M (1957) Neonatal and maternal thrombocytopenic purpura due to quinidine. Pediatrics 19:84–87

    Google Scholar 

  56. McKenna WJ, Harris L, Rowland E, Whitelaw A, Storey G, Holt D (1983) Amiodarone therapy during pregnancy. Am J Cardiol 51:1231–1233

    CAS  PubMed  Google Scholar 

  57. Mendelson CL (1956) Disorder of the heartbeat during pregnancy. Am J Obstet Gynecol 72:1268–1301

    Google Scholar 

  58. Meyer J, Lackner JE, Schochet SS (1930) Paroxysmal tachycardia in pregnancy. JAMA 94:1901–1904

    Google Scholar 

  59. Mitani GM, Steinberg I, Lien EJ, Harrison EC, Elkayam U (1987) The pharmacokinesis of antiarrhythmic agents in pregnancy and lactation. Clin Pharmacokinet 12:253–291

    CAS  PubMed  Google Scholar 

  60. Mosby (1997) Mosby's complete drug reference, 7th edn. Mosby, St. Louis

  61. Natale A, Davidson T, Geiger MY, Newby K (1997) Implantable cardioverters-defibrillators and pregnancy: a safe combination? Circulation 96:2808–2812

    CAS  PubMed  Google Scholar 

  62. Page RL (1995) Treatment of arrhythmias during pregnancy. Am Heart J 130:871–876

    CAS  PubMed  Google Scholar 

  63. Palmer CM, Norris MC (1990) Placental transfer of flecainide. Am J Dis Child 144:144

    CAS  Google Scholar 

  64. Perloff J (1991) Pregnancy and congenital heart disease. J Am Coll Cardiol 18:340–342

    CAS  PubMed  Google Scholar 

  65. Potondi A (1967) Congenital rhabdomyoma of the heart and intrauterine digitalis poisoning. J Forensic Sci 11:81–88

    Google Scholar 

  66. Prystowsky EN (1988) Diagnosis and management of the preexcitation syndromes. Curr Probl Cardiol 13:225–310

    CAS  PubMed  Google Scholar 

  67. Requena M, García-Cosío F, Fernández-Yáñez J, García-Alarilla M, Bajo J (1985) Tratamiento de la estenosis mitral con propranolol durante el embarazo y el puerperio. Med Clin (Barc) 85:412–414

    Google Scholar 

  68. Rotmensch HH, Elkayam U, Frishman W (1983) Antiarrhythmic drug therapy during pregnancy. Ann Intern Med 98:487–497

    CAS  PubMed  Google Scholar 

  69. Rotmensch HH, Rotmensch S, Elkayam U (1987) Management of cardiac arrhythmias during pregnancy. Drugs 33:623–633

    CAS  PubMed  Google Scholar 

  70. Rubin PC, Butters L, Clark D, Sumner D, Belfield A, Pledger D et al (1984) Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor agonist atenolol. Am J Obstet Gynecol 150:389–392

    CAS  PubMed  Google Scholar 

  71. Sandström B (1978) Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy. Gynecol Obstet Invest 9:195–204

    Google Scholar 

  72. Sandström B (1982) Adrenergic beta-receptor blockers in hypertension of pregnancy. Clin Exp Hypertens 1:127–141

    Google Scholar 

  73. Schroeder JS, Harrison DC (1971) Repeated cardioversion during pregnancy. Am J Cardiol 27:445–449

    CAS  PubMed  Google Scholar 

  74. Serafini PC, Petracco A, Vicosa HM, Costa PL (1979) Arterial hyposensitive effect of verapamil in severe pre-eclampsia: preliminary study. Arq Bras Cardiol 32:57–61

    CAS  PubMed  Google Scholar 

  75. Sherman JL, Locke RV (1960) Transplacental neonatal digitalis intoxication. Am J Cardiol 6:834–837

    Google Scholar 

  76. Shnider SM, Way EL (1968) Plasma levels of lidocaine (Xylocaine) in mother and newborn following obstetrical conduction anesthesia: clinical applications. Anesthesiology 29:951–958

    CAS  PubMed  Google Scholar 

  77. Sholan A, Ostzega E, Mehra A, Johnson JV, Elkayam U (1997) Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 79:1061–1064

    Article  PubMed  Google Scholar 

  78. Tamari I, Eldar M, Rabinowitz B, Neufeld HN (1982) Medical treatment of cardiovascular disorders during pregnancy. Am Heart J 104:1357–1363

    CAS  PubMed  Google Scholar 

  79. Tcherdakoff PH, Colliard M, Berrard E, Kreft C, Dupay A, Bernaille JM (1978) Propranolol in hypertension during pregnancy. Br Med J 2:670

    CAS  PubMed  Google Scholar 

  80. Teuscher A, Bossi E, Imhof P (1978) Effect of propranolol on fetal tachycardia in diabetic pregnancy. Am J Cardiol 42:304–307

    CAS  PubMed  Google Scholar 

  81. Turner GM, Oakley CM, Dixon HG (1968) Management of pregnancy complicated by hypertrophic obstructive cardiomyopathy. Br Med J 4:281–284

    CAS  PubMed  Google Scholar 

  82. Turnstall ME (1969) The effect of propranolol on the onset of breathing at birth [abstract]. Br J Anaesth 41:792

    Google Scholar 

  83. Ulmsten U (1979) Inhibition of myometrial hyperactivity by Ca antagonist. Dan Med Bull 26:125

    CAS  PubMed  Google Scholar 

  84. Van Engelen AD, Weijtens O, Brenner JI, Kleinman CS, Copel JA, Stoutenbeek P et al (1994) Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 24:1371–1375

    PubMed  Google Scholar 

  85. Van Gelder-Hasker MR, De Jong CL, De Vries JI, Van Geijn HP (1995) The effect of flecainide acetate for fetal tachycardia and fetal hydrops. J Pediatr 126:988–990

    PubMed  Google Scholar 

  86. Vaughan Williams EM (1984) A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 24:129–147

    PubMed  Google Scholar 

  87. Wagner X, Jouglar J, Moulin M, Miller AM, Petitjean J, Pisapia A (1990) Coadministration of flecainide acetate and sotalol during pregnancy: lack of teratogenic effects, passage across the placenta, and excretion in human breast milk. Am Heart J 119:700–702

    CAS  PubMed  Google Scholar 

  88. Webster LJ (1990) Drugs used in the chemotherapy of protozoal infections—malaria. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gillman's the pharmacological basis of therapeutics, 8th edn. Pergamon, New York, p 978

  89. Widerhorn J, Bhandari AK, Bughi S, Rahimtoola SH, Elkayam U (1991) Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy. Am Heart J 122:1162–1166

    CAS  PubMed  Google Scholar 

  90. Widerhorn J, Widerhorn ALM, Rahimtoola SH, Elkayam U (1992) WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. Am Heart J 123:796–798

    CAS  PubMed  Google Scholar 

  91. Wolff F, Breuker KH, Schlensker KH, Bolte A (1980) Prenatal diagnosis and therapy of fetal heart rate anomalies: with a contribution on placental transfer of verapamil. J Perinatal Med 8:203–208

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simone Ferrero.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferrero, S., Colombo, B.M. & Ragni, N. Maternal arrhythmias during pregnancy. Arch Gynecol Obstet 269, 244–253 (2004). https://doi.org/10.1007/s00404-002-0461-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-002-0461-x

Keywords

Navigation